Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

AbbVie Inc., consolidated balance sheet: assets (quarterly data)

US$ in millions

	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash and equivalents	5,229)	5,629)	6,467)	5,175)	5,524)	7,257)	13,130)	18,067)	12,814)	13,287)	8,759)	6,711)	9,201)	11,832)	8,521)	6,098)	9,746)	12,182)	8,546)	9,755)
Short-term investments	28)	42)	—)	1)	31)	28)	27)	2)	2)	3)	7)	11)	28)	47)	1,440)	1,474)	84)	67)	54)	22)
Accounts receivable, net	12,589)	12,769)	12,637)	12,477)	10,919)	11,472)	11,724)	11,949)	11,155)	11,412)	11,491)	11,473)	11,254)	10,743)	11,237)	10,733)	9,977)	9,281)	9,914)	9,588)
Inventories	4,951)	4,938)	4,960)	4,526)	4,181)	4,450)	4,218)	4,245)	4,099)	3,981)	4,055)	3,833)	3,579)	3,172)	3,396)	3,483)	3,128)	3,094)	3,386)	3,272)
Prepaid expenses and other	6,265)	5,161)	5,197)	5,496)	4,927)	4,578)	4,717)	4,608)	4,932)	4,541)	4,540)	4,460)	4,401)	4,570)	4,506)	4,721)	4,993)	4,333)	4,099)	3,932)
Current assets	29,062)	28,539)	29,261)	27,675)	25,582)	27,785)	33,816)	38,871)	33,002)	33,224)	28,852)	26,488)	28,463)	30,364)	29,100)	26,509)	27,928)	28,957)	25,999)	26,569)
Investments	268)	291)	310)	287)	279)	267)	272)	305)	304)	275)	288)	257)	241)	235)	244)	260)	277)	272)	266)	305)
Property and equipment, net	5,628)	5,483)	5,283)	5,237)	5,134)	5,141)	5,023)	4,980)	4,989)	4,934)	4,943)	4,931)	4,935)	4,893)	4,958)	5,075)	5,110)	5,130)	5,161)	5,193)
Intangible assets, net	52,641)	54,315)	57,031)	58,489)	60,068)	66,646)	60,243)	62,225)	55,610)	58,603)	62,862)	64,848)	67,439)	68,725)	71,823)	73,986)	75,951)	77,456)	79,340)	81,293)
Goodwill	35,640)	35,626)	35,638)	35,285)	34,956)	35,295)	33,386)	33,426)	32,293)	32,091)	32,224)	32,220)	32,156)	31,726)	32,028)	32,298)	32,379)	32,296)	32,398)	32,349)
Other assets	10,721)	9,644)	9,659)	9,192)	9,142)	8,288)	9,197)	9,067)	8,513)	7,094)	6,198)	5,800)	5,571)	5,382)	5,033)	5,083)	4,884)	4,747)	4,808)	4,792)
Long-term assets	104,898)	105,359)	107,921)	108,490)	109,579)	115,637)	108,121)	110,003)	101,709)	102,997)	106,515)	108,056)	110,342)	110,961)	114,086)	116,702)	118,601)	119,901)	121,973)	123,932)
Total assets	133,960)	133,898)	137,182)	136,165)	135,161)	143,422)	141,937)	148,874)	134,711)	136,221)	135,367)	134,544)	138,805)	141,325)	143,186)	143,211)	146,529)	148,858)	147,972)	150,501)

The asset composition of the company exhibits several notable trends over the observed period from March 2021 to December 2025. Current assets demonstrate fluctuations, while long-term assets generally show a declining trend, albeit with some periods of increase. A detailed examination of individual asset categories reveals specific patterns.

Liquidity and Current Assets: Current assets experienced a decrease from approximately US$26.6 billion in March 2021 to a low of US$25.999 billion in June 2021, followed by an increase to US$28.957 billion in September 2021. A subsequent decline occurred through December 2022, reaching US$28.463 billion. A significant increase is observed in March 2024 to US$38.871 billion, followed by a decrease to US$25.582 billion by December 2024, and a slight recovery to US$29.062 billion by December 2025. Within current assets, cash and equivalents show considerable volatility, ranging from a high of US$18.067 billion in March 2024 to a low of US$5.229 billion in December 2025. Accounts receivable, net, remained relatively stable, generally fluctuating between US$10.7 billion and US$12.7 billion throughout the period. Inventories exhibited a gradual increase from US$3.272 billion in March 2021 to US$4.951 billion in December 2025. Prepaid expenses and other assets also showed a general upward trend, increasing from US$3.932 billion to US$6.265 billion over the same period.
Short-Term Investments: Short-term investments were minimal for most of the period, generally below US$1 billion. A notable increase occurred in March 2022, reaching US$1.474 billion, but subsequently declined to very low levels by December 2025.
Long-Term Assets: Total long-term assets decreased from US$123.932 billion in March 2021 to US$104.898 billion in December 2025. Intangible assets, net, represent the largest component of long-term assets and demonstrate a consistent decline from US$81.293 billion to US$52.641 billion. Goodwill also decreased, moving from US$32.349 billion to US$35.640 billion, with fluctuations in between. Property and equipment, net, remained relatively stable, fluctuating around US$5 billion, with a slight increase to US$5.628 billion by December 2025. Investments showed a slight increase over the period, from US$305 million to US$268 million. Other assets increased from US$4.792 billion to US$10.721 billion.
Total Assets: Total assets followed the trend of long-term assets, decreasing from US$150.501 billion in March 2021 to US$133.960 billion in December 2025. The largest decrease occurred between December 2022 and December 2024, followed by a slight recovery. The significant increase in current assets in March 2024 contributed to a temporary increase in total assets, but this was not sustained.

The observed trends suggest a strategic shift in asset allocation, with a decrease in long-term intangible assets and goodwill, potentially due to amortization, impairment, or divestitures. The fluctuations in cash and equivalents indicate active cash management. The increase in inventories and prepaid expenses may suggest increased operational activity or changes in payment terms. Overall, the company’s asset base experienced a net reduction over the analyzed period.

AbbVie Inc. (NYSE:ABBV)

Balance Sheet: Assets
Quarterly Data

Assets: Selected Items

Current Assets: Selected Items

AbbVie Inc. (NYSE:ABBV)

Balance Sheet: Assets Quarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data